Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 90: 1013-1019, 2001;
8750-7587/01 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (25)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Simon, M.
Right arrow Articles by Maltais, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Simon, M.
Right arrow Articles by Maltais, F.
Vol. 90, Issue 3, 1013-1019, March 2001

Limitation of lower limb VO2 during cycling exercise in COPD patients

Mathieu Simon1, Pierre LeBlanc1, Jean Jobin1, Marc Desmeules1, Martin J. Sullivan2, and François Maltais1

1 Centre de Recherche, Hôpital Laval, Institut Universitaire de Cardiologie et de Pneumologie de l'Université Laval, Sainte-Foy, Québec, Canada G1V 4G5; and 2 Department of Medicine, Division of Cardiology, Duke University Medical Center, Durham, North Carolina 27710


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Patients with chronic obstructive pulmonary disease (COPD) usually stop exercise before reaching physiological limits in terms of O2 delivery and extraction. A plateau in lower limb O2 uptake (VO2) and blood flow occurs despite progression of the imposed workload during cycling in some patients with COPD, suggesting that maximal capacity to transport O2 had been reached and that it had been extracted in the peripheral exercising muscles. This study addresses this observation. Symptom-limited incremental cycle exercise was performed by 14 men [62 ± 11 (SD) yr] with severe COPD (forced expiratory volume in 1 s = 35 ± 7% of predicted value). Leg blood flow was measured at each exercise step with a thermodilution catheter inserted in the femoral vein. This value was multiplied by two to account for both working legs (QLEGS). Arterial and femoral venous blood was sampled at each exercise step to measure blood gases. Leg O2 consumption (VO2LEGS) was calculated according to the Fick equation. Total body VO2 (VO2TOT) was measured from expired gas analysis, and tidal volume (VT) and minute ventilation (VE) were derived from the flow signal. In eight patients, VO2LEGS kept increasing in parallel with VO2TOT as external work rate was increasing. In six subjects, a plateau in VO2LEGS and QLEGS occurred during exercise (increment of <3% between 2 consecutive increasing workloads) despite the increase in workload and VO2TOT [corresponding mean was 110 ± 38 ml (11 ± 4%)]. These six patients also exhibited a plateau in O2 extraction during exercise. Peak exercise work rate was higher in the eight patients without a plateau than in the six with a plateau (51 ± 10 vs. 40 ± 13 W, P = 0.043). VT, VE, and dyspnea were significantly greater at submaximal exercise in patients of the plateau group compared with those of the nonplateau group. These results show that, in some patients with COPD, blood flow directed to peripheral muscles and O2 extraction during exercise may be limited. We speculate that redistribution of cardiac output and O2 from the lower limb exercising muscles to the ventilatory muscles is a possible mechanism.

oxygen uptake; chronic obstructive pulmonary disease


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

PATIENTS WITH ADVANCED chronic obstructive pulmonary disease (COPD) stop exercise because of exertional discomfort (12); in many of them, psychological factors such as anxiety, fear of dyspnea, and poor motivation may contribute to exercise intolerance (2). In these individuals, exercise termination is thought to occur before the physiological limits, in terms of O2 delivery and O2 extraction of the exercising muscles, have been reached (6, 10).

In conducting a study on lower limb perfusion during cycling exercise in patients with COPD, we noted that some individuals had a plateau in lower limb O2 uptake (VO2) despite progression of the imposed workload (16). According to the Fick principle, such a plateau in lower limb VO2 must be accompanied by a leveling off in leg blood flow and O2 extraction. If true, this observation suggests that, in some patients with COPD, lower limb VO2 may be physiologically limited during whole body cycling exercise.

The primary objective of this study was to address the hypothesis that the maximal ability to transport O2 to the peripheral muscles and extract it may be exhausted during whole body cycling exercise in a significant proportion of patients with severe COPD. This phenomenon should be demonstrated by a plateau in lower limb VO2 while external work rate is increasing. As a secondary objective, we assessed the possible impact of the plateau in lower limb VO2 on work capacity.


    METHODS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Patient Populations

Fourteen men with severe COPD volunteered to participate in this study. Only one of these patients participated in our previous investigation of the hemodynamic response of the lower limb during exercise in COPD (16). The diagnosis of COPD was based on current or past smoking history, clinical evaluation, and pulmonary function tests (1). To improve the homogeneity of this group of patients, other inclusion criteria included resting arterial PO2 (PaO2) above 60 Torr and body weight between 90 and 110% of ideal body weight. Subjects were stable at the time of the study, and none suffered from other significant medical conditions that could limit their capacity to perform an exercise test. No patients were taking systemic corticosteroids or were involved in a regular exercise training program. All but one patient were retired, and none reported heavy recreational activity. The research protocol was approved by the institutional ethics committee, and a written consent form was obtained from each patient.

Protocol

Catheter placements and leg blood flow measurements. Single-leg blood flow (QLEG) was measured with a thermodilution catheter (model 93 A-105-5F, Edwards Laboratory, Santa Ana, CA) as previously described and used in this laboratory (16, 24, 25). After the right groin was shaved, disinfected, and anesthetized with lidocaine, the catheter was inserted in the femoral vein 2 cm below the inguinal ligament with the distal thermistor tip positioned 10-12 cm above the inguinal ligament in the external iliac vein. The catheter was interfaced with a Gould Statham SP 1435 cardiac output computer (Oxnard, CA), and boluses of 1-5 ml iced or room temperature saline were injected to obtain two to four flow measurements at rest and during each exercise step. Thermodilution curves were displayed on the Gould recorder to ensure a monophasic curve with an exponential decay. The validity and reproducibility of the QLEG measurements, using this equipment and methodology, have been previously evaluated by Sullivan et al. (24, 25). In these studies, a close relation (r = 0.98, P < 0.01) was found between thermodilution flow measured with this catheter system and simultaneous paired electromagnetic flow probe measurements in a perfused canine preparation (24). The variability of this measurement in healthy subjects and in patients with heart failure in whom duplicate submaximal exercise tests were performed was 16 ± 9% (25). To sample the femoral venous blood, an indwelling catheter was also inserted in the right femoral vein 1 cm below the thermodilution catheter. Finally, a cannula was placed in a radial artery.

Exercise test. Subjects were seated on an electrically braked ergocycle and connected to a gas-analysis system through a mouthpiece. This gas-analysis system consisted of a pneumotachograph, O2 and CO2 analyzers, and a mixing chamber (Quinton QMC, Quinton, Bothell, WA). After subjects rested for 5 min, a progressive and symptom-limited stepwise exercise test, with room air breathing and starting at a work rate of 10 W, was performed. Each exercise step lasted 3 min, and increments of 10 W were used. At rest and during exercise, five-breath averages of VO2 and minute ventilation (VE) were obtained, and respiratory rate (RR) and tidal volume (VT) were derived from the flow signal. Dyspnea and leg fatigue perception were rated during the last minute of each exercise step using the Borg 10-point scale (3). QLEG measurements were obtained during the second minute of each exercise step; the arterial and femoral blood were sampled during the last minute. Because QLEG measurements were obtained before blood sampling and probably before a steady state was reached, a small error in leg VO2 calculation can be expected. Our laboratory has previously estimated that this may lead to an ~5% underestimation in leg VO2 (16). Blood samples were placed in iced water until the end of the exercise test and processed within 30 min of withdrawal. Blood pressure was measured from the arm that was not cannulated during the last minute of each exercise step using an automated stress-testing blood pressure monitor (Quinton Q412).

Arterial and venous PO2, PCO2, and pH were measured with a blood-gas machine (AVL 995, AVL Scientific, Roswell, GA), and O2 saturation was measured with a CO-oximeter (OSM2 Hemoximeter, Radiometer, Copenhagen, Denmark). Blood-gas values were taken at 37°C. After blood was centrifuged at room temperature, plasmatic lactate concentrations were determined with an enzymatic technique (Kit lactate, Boehringer Mannheim, Mannheim, Germany).

Calculation. The alveolar-arterial PO2 difference (A-aDo2) was calculated with the following formula (PB - PH2o × FIO2- PaCO2/RER, where PB is barometric pressure, PH2o is water vapor pressure, PaCO2 is arterial PCO2, and RER is respiratory exchange ratio. Arterial and venous O2 contents (CaO2 and CfvO2, respectively) were calculated with the following formula: 1.39 × Hb × O2 saturation + 0.003 × PO2. QLEG measurements were multiplied by two to account for both exercising legs (QLEGS). Leg VO2 (VO2LEGS) was calculated from the arterial-femoral venous O2 content difference (CaO2-CfvO2) multiplied by QLEGS (Fick principle). The leg O2 extraction ratio was calculated from CaO2 divided by the difference between CaO2 and CfvO2. Leg vascular resistance was calculated as the ratio of mean blood pressure to QLEGS.

Statistical Analysis

Results are expressed as means ± SD. The predicted values used for spirometry, lung volume, and lung CO-diffusing capacity are those of Knudson et al. (13), Goldman and Becklake (7), and Cotes and Hall (5), respectively. The maximal voluntary ventilation (MVV) was estimated by multiplying forced expiratory volume in 1 s (FEV1) by 35 (4). A plateau in QLEGS and VO2LEGS during exercise was defined a priori by an increment of <3% between two consecutive workloads (17). Changes in VO2LEGS, QLEGS, and CaO2-CfvO2 during the course of the exercise were compared between patients with and without a plateau in VO2LEGS using profile analysis (23). Resting and exercise characteristics of patients with and without a plateau in their VO2LEGS were compared using unpaired two-tailed Student's t-tests.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Patient Characteristics

Patient characteristics are presented in Table 1. On average, they had a normal body mass index (20-25 kg/m2), severe airflow obstruction with an FEV1 of 35 ± 7% of predicted, slight reduction in PaO2, and normal resting PaCO2. Each subject completed a symptom-limited incremental exercise test with peak power output ranging from 30 to 70 W. All subjects had classical evidence of ventilatory and gas-exchange limitation at peak exercise such as peak VE-to-MVV ratio (peak VE/MVV) > 1 (1.04 ± 0.25), arterial O2 desaturation (change in arterial O2 saturation from rest to peak exercise of -5 ± 4%), and CO2 retention (Delta PaCO2 from rest to peak exercise of +6 ± 4 Torr).

                              
View this table:
[in this window]
[in a new window]
 
Table 1.   Subjects' characteristics at rest

VO2LEGS and Total Body VO2

In 6 of the 14 subjects, a plateau in VO2LEGS was found (Fig. 1). In these subjects, the changes in VO2LEGS between peak exercise and the immediately preceding workload was -9 ± 9%. The remaining eight patients demonstrated a 24 ± 10% increase in VO2LEGS between peak exercise and the immediately preceding workload.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 1.   Leg O2 consumption (VO2LEGS)-work rate relationship in the 6 patients of the plateau group. As can be seen, a plateau in VO2LEGS occurred in these patients despite the progression in work rate.

The average time courses of changes in total body VO2 (VO2TOT), VO2LEGS, QLEGS, and CaO2-CfvO2 during exercise for patients with and without a plateau in VO2LEGS are provided in Fig. 2. As can be seen in the plateau group, VO2TOT was still increasing [mean Delta VO2TOT between the last two workloads = 110 ± 38 ml (11 ± 4%)] despite the occurrence of a plateau in VO2LEGS. The time course of change in VO2TOT during exercise was similar between the two groups, with no evidence of a plateau. Peak VO2TOT achieved in both groups of patients was not statistically different (0.99 ± 0.19 vs. 0.96 ± 0.17 l/min in the plateau group and the nonplateau group, respectively). In contrast, the time courses of changes in VO2LEGS, QLEGS, and CaO2-CfvO2 during exercise were significantly different between the two groups as indicated by the profile analysis (P = 0.001). As expected, the plateau in VO2LEGS (Fig. 2A) was accompanied by a corresponding phenomenon in QLEGS (Fig. 2C) and in CaO2-CfvO2 (Fig. 2E). The O2 extraction ratio also plateaued in the plateau group to reach 68 ± 12%, whereas it increased progressively throughout the exercise period in the nonplateau group up to a value of 75 ± 9% (P > 0.05).


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 2.   Total body VO2 (VO2TOT)-work rate and VO2LEGS-work rate (A and B), blood flow for both legs (QLEGS)-work rate (C and D), and arterial-femoral venous O2 content difference (CaO2-CfvO2)-work rate (E and F) relationships obtained in the group demonstrating (left) or not demonstrating (right) a plateau in VO2LEGS. CaO2-CfvO2 is abbreviated as Ca-CvO2. In the nonplateau group, VO2LEGS, QLEGS, and CaO2-CfvO2 kept progressing while external work rate was increasing. In the other group, a plateau in VO2LEGS, QLEGS, and CaO2-CfvO2 could be demonstrated despite the progression in VO2TOT and work rate. *P = 0.001 with the corresponding relationship in the plateau group.

Comparison Between the Plateau and Nonplateau Group

Peak workload achieved was greater in the nonplateau group than in the plateau group (51 ± 10 vs. 40 ± 13 W, P = 0.043) (Table 2). Work efficiency was significantly different between the two groups with a higher Delta VO2TOT-to-Delta work rate ratio in the plateau group (17.1 ± 3.6 ml O2/W) compared with the nonplateau group (12.9 ± 2.7 ml O2/W, P = 0.029). At peak exercise, the VO2LEGS-to-VO2TOT ratio was significantly lower in the plateau group than in the nonplateau group, averaging 52 ± 21% and 72 ± 10%, respectively (P = 0.040).

                              
View this table:
[in this window]
[in a new window]
 
Table 2.   Parameters at peak exercise in both groups of patients

Patients of the two groups could not be differentiated on the basis of their pulmonary function, blood gases, and Hb concentration (Table 1). Body mass index and resting A-aDO2 were smaller in patients of the nonplateau group compared with those of the plateau group (P = 0.037 and 0.033, respectively). QLEGS and CaO2-CfvO2 tended to be greater at peak exercise in the nonplateau group (Table 2). As a result, peak VO2LEGS was significantly greater in the nonplateau group than in the plateau group (P = 0.036). Leg vascular resistance at peak exercise was higher in the plateau group than in the nonplateau group (P = 0.044). Both groups experienced similar degrees of exercise-induced arterial O2 desaturation, CO2 retention, and acidosis. The time courses of changes in breathing pattern, symptom scores, and heart rate during exercise for both groups are shown in Fig. 3. VT, VE, and dyspnea were significantly greater at submaximal exercise in patients of the plateau group compared with those of the nonplateau group. These values were similar at peak exercise in both groups. The changes in RR and heart rate during exercise were similar for the two groups.


View larger version (37K):
[in this window]
[in a new window]
 
Fig. 3.   Respiratory rate (RR; A), tidal volume (VT; B), minute ventilation (VE; C), dyspnea (D), leg fatigue scores (E), and heart rate (F) at rest (R) and during submaximal (open symbols) and peak (solid symbols) exercise in patients of the plateau group (open and solid circles) and those of the nonplateau group (open and solid squares). Peak exercise values for all these parameters were similar in both groups. VT, VE, and dyspnea were significantly greater at submaximal exercise in patients of the plateau group compared with those of the nonplateau group. The changes in RR and heart rate during exercise were similar for the 2 groups. The exact P values of the comparisons that reached statistical significance are provided along the x-axes.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

In this study, two behaviors of the VO2LEGS-work rate relationship were found during cycling exercise in patients with COPD. In one subgroup of patients, VO2LEGS kept progressing in a parallel fashion to VO2TOT, whereas external work rate was increasing. In other patients, a plateau in VO2LEGS occurred despite the progression in VO2TOT and work rate. As expected from the Fick principle, this plateau in VO2LEGS was accompanied by a leveling off in QLEGS and in CaO2-CfvO2. These results indicate that, despite evidences of ventilatory limitation, some patients with COPD exhaust their maximal ability to transport and extract O2 in the peripheral muscles during whole body cycling exercise. Furthermore, these limitations may have detrimental effects on exercise tolerance, as indicated by the lower work capacity in the plateau group compared with the nonplateau group despite similar peak VO2TOT between the two groups. Thus work efficiency was lower in patients of the plateau group.

In patients exhibiting a plateau in VO2LEGS, the increase in VO2TOT toward end-exercise values could only be explained by an increase in metabolic activity outside the legs. If we assume that total cardiac output did not plateau, the only remaining physiological explanation for the plateau in VO2LEGS and in QLEGS is a redistribution of blood flow and O2 from the exercising muscle toward another group of muscles. Although measurements of total cardiac output would have been necessary to exclude a plateau in total cardiac output, we believe that this possibility is unlikely for two reasons. First, no patients displayed any symptoms or signs of left or right ventricular dysfunction and coronary heart disease, according to their past medical history, physical examination, resting and exercise electrocardiogram, and chest X-ray. Second, considering the parallel relationship between VO2 and cardiac output during exercise (18), the fact that VO2TOT kept increasing until end exercise suggests that total cardiac output was not limited in our patients.

Such a redistribution of blood flow between the lower limb and respiratory muscles has been elegantly documented in elite athletes (VO2TOT = 64 ± 6 ml · kg-1 · min-1) by Harms and colleagues (8, 9). By manipulating the work of breathing during near maximal exercise, these authors provided strong evidence that, in elite athletes, cardiac output can be redistributed between the exercising peripheral muscles and the ventilatory muscles. Accordingly, we speculate that the most likely candidates for the possible blood flow redistribution in our patients are the respiratory muscles, with VO2 during exercise that might be sufficiently high in severe COPD to compete with the lower limb muscles for the available blood flow and O2 (15). Because each patient had severe airflow obstruction, why then did only 6 of 14 patients exhibit a plateau in VO2LEGS? A potential explanation is that there was a marked difference in work of breathing between the two groups as suggested by the greater VT, VE, and dyspnea at submaximal exercise intensity in patients of the plateau group compared with those of the nonplateau group. This supports the idea that work of breathing and presumably O2 and blood flow requirements of the ventilatory muscles might have differed considerably between the two groups.

To provide a stronger conclusion on the concept of blood flow redistribution, it would have been necessary to measure and compare work of breathing between the two groups of patients and to evaluate the effects of changing work of breathing (with noninvasive ventilatory assistance for instance) on QLEGS and the VO2LEGS-work rate relationship during exercise (8). If our data interpretation is correct, an increase in QLEGS in patients of the plateau group should occur with respiratory muscle unloading. Richardson and colleagues (19) recently evaluated the effects of the respiratory muscle unloading in COPD patients who breathed a helium mixture during whole body cycling exercise (high ventilatory requirement) and single-knee extension exercise (low ventilatory requirement). Consistent with the concept of blood flow redistribution, they found that breathing the helium mixture was associated with higher peak VO2 only during whole body cycling exercise. Breathing a helium mixture during single-knee extension exercise did not improve peak VO2 presumably because the maximum ventilation and the demand placed on the respiratory muscles were lower during this exercise modality, therefore reducing the potential of blood flow redistribution from the respiratory to the knee-extensor muscles.

The mechanisms through which blood flow and O2 could be distributed preferentially to respiratory muscles or other muscles and not to peripheral muscles were not explored in the present study. It has been suggested that the diaphragm and other respiratory muscles may have a greater potential for exercise-induced vasodilatation compared with peripheral muscles because of their higher oxidative capacity (14). It has also been shown that increased respiratory muscle activity may increase systemic sympathetic activity, causing peripheral vasoconstriction at peak exercise (8). Such a mechanism may have occurred in our patients of the plateau group, which had a leg vascular resistance that was higher than in patients of the nonplateau group.

In addition to the plateau in QLEGS, a limitation in leg O2 extraction was necessary to obtain a plateau in VO2LEGS. In the presence of a stable QLEGS, this suggests that an impairment in O2 transfer to the muscle may have contributed to the limitation in VO2LEGS in patients of the plateau group (20). The analysis of the muscle structure was beyond the scope of this study, but a possible explanation for this is a reduction in muscle capillarization, which has previously been reported in patients with COPD (26). An alternative mechanism for the impairment in muscle O2 conductance is a mismatch between the perfusion of the contracting muscle units and their metabolic activity (21). The limitation in O2 extraction during exercise supports the concept of a peripheral component to exercise limitation, at least in some patients with COPD.

Measurement of leg blood flow is technically difficult, and a key question is whether the occurrence of a plateau in VO2LEGS was a true physiological phenomenon or a technical artifact. The former interpretation is supported by two evidences. First, in one patient, the experimental procedure was performed on two separate occasions; in addition to being involved in the present study, this patient also participated in our previous investigation on leg blood flow measurements in COPD (16). In both circumstances, VO2LEGS plateaued at 40 W. Second, the work efficiency was lower in the plateau group compared with the nonplateau group. This indicates, independently of VO2LEGS measurements, that a greater proportion of VO2TOT was devoted to other muscles rather than to the lower limb muscles, supporting our data interpretation that increased aerobic activity outside the lower limb exercising muscles was occurring in our patients.

In the present investigation, blood-gas values were reported at 37°C because changes in body temperature were modest at the level of exercise reached by our patients (change in rectal temperature measured with a thermocouple inserted 12-15 cm beyond the anal sphincter <0.5°C; Maltais, LeBlanc, and Johnson, unpublished observations). Assuming a similar change in arterial blood and rectal temperature and a change in femoral venous blood temperature 0.5°C greater than rectal temperature (22), we calculated that arterial and venous O2 saturation values would be underestimated by ~2% and 6%, respectively (11). Because both errors are in the same direction and happened to be of similar absolute magnitude, they tend to cancel each other out. As a result, CaO2-CfvO2 and VO2LEGS would be underestimated by only 1-2% by avoiding to correct blood-gas values for body temperature changes during exercise.

In summary, the present results indicate that some patients with COPD and severe airflow obstruction may reach their physiological limits in terms of lower limb VO2, blood flow, and O2 extraction during cycling exercise. Exercise tolerance was lower in patients exhibiting these limitations. The present results are consistent with the possibility of a blood flow redistribution between the respiratory and lower limb muscles in patients with COPD.


    ACKNOWLEDGEMENTS

We are grateful to Marthe Bélanger, Marie-Josée Breton, and François Whittom for collaboration. We thank Serge Simard for statistical assistance and colleagues from the Centre de Pneumologie de l'Hôpital Laval for supporting the research.


    FOOTNOTES

This study was supported in part by the Fonds de la recherche en santé du Québec, by la fondation JD Bégin, Université Laval, and by Bayer. F. Maltais is a clinician-scientist of the Fonds de la recherche en santé du Québec.

Address for reprint requests and other correspondence: F. Maltais, Centre de Pneumologie, Hôpital Laval, 2725 Chemin Sainte-Foy, Sainte-Foy, Québec, Canada G1V 4G5 (E-mail: medfma{at}hermes.ulaval.ca).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Received 1 May 2000; accepted in final form 12 September 2000.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

1.   American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 136: 225-244, 1987[ISI][Medline].

2.   Belman, MJ. Exercise in patients with chronic obstructive pulmonary disease. Thorax 48: 936-946, 1993[Abstract].

3.   Borg, G. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 14: 377-381, 1982[ISI][Medline].

4.   Clark, TJH, Freedman S, Campbell EJM, and Winn R. The ventilatory capacity of patients with chronic airway obstruction. Clin Sci (Colch) 36: 307-316, 1969[ISI][Medline].

5.   Cotes, JE, and Hall AM. The transfer factors for the lung; normal values in adults. In: Normal Values for Respiratory Function in Man, edited by Arcangeli P.. Torino, Italy: Panminerva Medica, 1970, p. 327-343.

6.   Gallagher, CG. Exercise limitation and clinical exercise testing in chronic obstructive pulmonary disease. Clin Chest Med 15: 305-326, 1994[ISI][Medline].

7.   Goldman, HI, and Becklake MR. Respiratory function tests: normal values at median altitudes and the prediction of normal results. Am Rev Tuberc 79: 454-467, 1959.

8.   Harms, CA, Babcock MA, McClaran SR, Pegelow DF, Nickele GA, Nelson WB, and Dempsey JA. Respiratory muscle work compromises leg blood flow during maximal exercise. J Appl Physiol 82: 1573-1583, 1997[Abstract/Free Full Text].

9.   Harms, CA, Wetter TJ, McClaran SR, Pegelow DF, Nickele GA, Nelson WB, Hanson P, and Dempsey JA. Effects of respiratory muscle work on cardiac output and its distribution during maximal exercise. J Appl Physiol 85: 609-618, 1998[Abstract/Free Full Text].

10.   Jones, NL, Jones GL, and Edwards RHT Exercise tolerance in chronic airway obstruction. Am Rev Respir Dis 103: 477-491, 1971[ISI][Medline].

11.   Kelman, GR, and Nunn JF. Nomograms for correction of blood PO2, PCO2, pH, and base excess for time and temperature. J Appl Physiol 21: 1484-1490, 1966[Free Full Text].

12.   Killian, KJ, LeBlanc P, Martin DH, Summers E, Jones NL, and Campbell EJM Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with airflow limitation. Am Rev Respir Dis 146: 935-940, 1992[ISI][Medline].

13.   Knudson, RJ, Slatin RC, Lebowitz MD, and Burrows B. The maximal expiratory flow-volume curve. Normal standards, variability and effects of age. Am Rev Respir Dis 113: 587-600, 1976[ISI][Medline].

14.   Laughlin, MH, Klabunde RE, Delp MD, and Armstrong RB. Effects of dipyridamole on muscle blood flow in exercising miniature swine. Am J Physiol Heart Circ Physiol 257: H1507-H1515, 1989[Abstract/Free Full Text].

15.   Levison, H, and Cherniack RM. Ventilatory cost of exercise in chronic obstructive pulmonary disease. J Appl Physiol 25: 21-27, 1968[Free Full Text].

16.   Maltais, F, Jobin J, Sullivan MJ, Bernard S, Whittom F, Killian KJ, Desmeules M, Bélanger M, and LeBlanc P. Metabolic and hemodynamic responses of the lower limb during exercise in patients with COPD. J Appl Physiol 84: 1573-1580, 1998[Abstract/Free Full Text].

17.   Mercier, J, Grobois J-M, and Préfaut C. Interprétation de l'épreuve d'effort. Rev Pneumol Clin 53: 289-296, 1997[Medline].

18.   Mitchell, JH, and Blomqvist G. Maximal oxygen uptake. N Engl J Med 284: 1018-1022, 1970.

19.   Richardson, RS, Sheldon J, Poole DC, Hopkins SR, Ries AL, and Wagner PD. Evidence of skeletal muscle metabolic reserve during whole body exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 159: 881-885, 1999[Abstract/Free Full Text].

20.   Roca, J, Hogan MC, Story D, Bebout DE, Haab P, Gonzalez R, Ueno O, and Wagner PD. Evidence for tissue diffusion limitation of VO2max in normal humans. J Appl Physiol 67: 291-299, 1989[Abstract/Free Full Text].

21.   Rowell, LB. Limitations to oxygen uptake during dynamic exercise. In: Human Cardiovascular Control, edited by Rowell LB.. New York: Oxford Univ. Press, 1993, p. 326-370.

22.   Saltin, B, and Hermansen L. Esophageal, rectal, and muscle temperature during exercise. J Appl Physiol 21: 1757-1762, 1966[Free Full Text].

23.   Srivastava, MS, and Carter EM. Repeated measures and profile analysis. In: An Introduction to Applied Multivariate Statistic. New York: Elsevier Science, 1983, p. 194-230.

24.   Sullivan, MJ, Beckley PD, Hanson KM, and Leier CV. In vivo validation of a thermodilution system designed to measure peripheral blood flow. Med Instrum 19: 38-40, 1985[ISI][Medline].

25.   Sullivan, MJ, Higginbotham MB, and Cobb FR. Exercise training in patients with severe left ventricular dysfunction. Hemodynamic and metabolic effects. Circulation 78: 506-515, 1988[ISI][Medline].

26.   Whittom, F, Jobin J, Simard PM, LeBlanc P, Simard C, Bernard S, Belleau R, and Maltais F. Histochemical and morphological characteristics of the vastus lateralis muscle in COPD patients. Comparison with normal subjects and effects of exercise training. Med Sci Sports Exerc 30: 1467-1474, 1998[ISI][Medline].


J APPL PHYSIOL 90(3):1013-1019
8750-7587/01 $5.00 Copyright © 2001 the American Physiological Society



This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
L. M. Romer and M. I. Polkey
Exercise-induced respiratory muscle fatigue: implications for performance
J Appl Physiol, March 1, 2008; 104(3): 879 - 888.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
R. A. Rabinovich, R. Bastos, E. Ardite, L. Llinas, M. Orozco-Levi, J. Gea, J. Vilaro, J. A. Barbera, R. Rodriguez-Roisin, J. C. Fernandez-Checa, et al.
Mitochondrial dysfunction in COPD patients with low body mass index
Eur. Respir. J., April 1, 2007; 29(4): 643 - 650.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
O. Georgiadou, I. Vogiatzis, G. Stratakos, A. Koutsoukou, S. Golemati, A. Aliverti, C. Roussos, and S. Zakynthinos
Effects of rehabilitation on chest wall volume regulation during exercise in COPD patients
Eur. Respir. J., February 1, 2007; 29(2): 284 - 291.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
L. M. Romer, A. T. Lovering, H. C. Haverkamp, D. F. Pegelow, and J. A. Dempsey
Effect of inspiratory muscle work on peripheral fatigue of locomotor muscles in healthy humans
J. Physiol., March 1, 2006; 571(2): 425 - 439.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. D. Miller, D. F. Pegelow, A. J. Jacques, and J. A. Dempsey
Effects of augmented respiratory muscle pressure production on locomotor limb venous return during calf contraction exercise
J Appl Physiol, November 1, 2005; 99(5): 1802 - 1815.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
A Aliverti, K Rodger, R L Dellaca, N Stevenson, A Lo Mauro, A Pedotti, and P M A Calverley
Effect of salbutamol on lung function and chest wall volumes at rest and during exercise in COPD
Thorax, November 1, 2005; 60(11): 916 - 924.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
P. T. Macklem
Cell and Molecular Biology Is not the Only Way to a Better Understanding of Pathogenesis of Lung Disease
Am. J. Respir. Crit. Care Med., July 1, 2004; 170(1): ii - iii.
[Full Text]


Home page
ThoraxHome page
A Aliverti, N Stevenson, R L Dellaca, A Lo Mauro, A Pedotti, and P M A Calverley
Regional chest wall volumes during exercise in chronic obstructive pulmonary disease
Thorax, March 1, 2004; 59(3): 210 - 216.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
F. Laghi and M. J. Tobin
Disorders of the Respiratory Muscles
Am. J. Respir. Crit. Care Med., July 1, 2003; 168(1): 10 - 48.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. J. Mador, O. Deniz, A. Aggarwal, and T. J. Kufel
Quadriceps Fatigability after Single Muscle Exercise in Patients with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., July 1, 2003; 168(1): 102 - 108.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. Velloso, S. G. Stella, S. Cendon, A. C. Silva, and J. R. Jardim
Metabolic and Ventilatory Parameters of Four Activities of Daily Living Accomplished With Arms in COPD Patients
Chest, April 1, 2003; 123(4): 1047 - 1053.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. J. Mador, E. Bozkanat, and T. J. Kufel
Quadriceps Fatigue After Cycle Exercise in Patients With COPD Compared With Healthy Control Subjects
Chest, April 1, 2003; 123(4): 1104 - 1111.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
G. L. Snider
Enhancement of Exercise Performance in COPD Patients by Hyperoxia: A Call for Research
Chest, November 1, 2002; 122(5): 1830 - 1836.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
F. Lotters, B. van Tol, G. Kwakkel, and R. Gosselink
Effects of controlled inspiratory muscle training in patients with COPD: a meta-analysis
Eur. Respir. J., September 1, 2002; 20(3): 570 - 577.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (25)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Simon, M.
Right arrow Articles by Maltais, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Simon, M.
Right arrow Articles by Maltais, F.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online